Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 31, 2019 - Issue 12
211
Views
2
CrossRef citations to date
0
Altmetric
Articles

Healthcare facility characteristics associated with achievement and maintenance of HIV viral suppression among persons newly diagnosed with HIV in New York City

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon &
Pages 1484-1493 | Received 06 Jul 2018, Accepted 11 Feb 2019, Published online: 25 Mar 2019

References

  • Aiken, L. H., Sloane, D. M., Lake, E. T., Sochalski, J., & Weber, A. L. (1999). Organization and outcomes of inpatient AIDS care. Medical Care, 37(8), 760–772. doi: 10.1097/00005650-199908000-00006
  • American Public Transportation Association. (2009). Transit ridership report: First quarter 2009. Washington, D.C.
  • Attia, S., Egger, M., Muller, M., Zwahlen, M., & Low, N. (2009). Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS (London, England), 23(11), 1397–1404. doi: 10.1097/QAD.0b013e32832b7dca
  • Beer, L., Bradley, H., Mattson, C. L., Johnson, C. H., Hoots, B., & Shouse, R. L. (2016). Trends in racial and ethnic disparities in antiretroviral therapy prescription and viral suppression in the United States, 2009–2013. Journal of Acquired Immune Deficiency Syndromes, 73(4), 446–453. doi: 10.1097/QAI.0000000000001125
  • Beer, L., Oster, A. M., Mattson, C. L., & Skarbinski, J. (2012). Racial disparities in antiretroviral therapy use and viral suppression among sexually active HIV-infected men who have sex with men—United States, medical Monitoring Project, 2009. In International AIDS Conference. Washington, DC.
  • Beer, L., Oster, A. M., Mattson, C. L., Skarbinski, J., & Medical Monitoring Project. (2014). Disparities in HIV transmission risk among HIV-infected black and white men who have sex with men, United States. AIDS (London, England), 28(1), 105–114. doi: 10.1097/QAD.0000000000000021
  • Benbow, N., Scheer, S., Wohl, A., Brady, K., Gagner, A., Hughes, A., & Townsell, S. (2012). Linkage, retention, ART use and viral suppression in four large cities in the United States. In International AIDS Conference. Washington, DC.
  • Centers for Disease Control and Prevention. (2011). Vital signs: HIV prevention through care and treatment–United States. MMWR Morbidity and Mortality Weekly Report, 60(47), 1618–1623.
  • Cozzi-Lepri, A., Phillips, A. N., Miller, V., Katlama, C., Ledergerber, B., Vella, S., & Lundgrens, J. D. (2003). Changes in viral load in people with virological failure who remain on the same HAART regimen. Antiviral Therapy, 8(2), 127–136.
  • Craw, J. A., Bradley, H., Gremel, G., West, B. T., Beer, L., & Weiser, J. (2017). Retention in care services reported by HIV care providers in the United States, 2013 to 2014. Journal of the International Association of Providers of AIDS Care (JIAPAC), 16(5), 460–466. doi: 10.1177/2325957417724204
  • Dombrowski, J. C., Kent, J. B., Buskin, S. E., Stekler, J. D., & Golden, M. R. (2012). Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS (London, England), 26(1), 77–86. doi: 10.1097/QAD.0b013e32834dcee9
  • Eberhart, M. G., Voytek, C. D., Hillier, A., Metzger, D. S., Blank, M. B., & Brady, K. A. (2014). Travel distance to HIV medical care: A geographic analysis of weighted survey data from the medical Monitoring Project in Philadelphia, PA. AIDS and Behavior, 18(4), 776–782. doi: 10.1007/s10461-013-0597-7
  • Fauci, A. S., Redfield, R. R., Sigounas, G., Weahkee, M. D., Giroir, B. P. (2019). Ending the HIV epidemic: A plan for the United States. JAMA. Advance online publication. doi:10.1001/jama.2019.1343
  • Gant, Z., Lomotey, M., Hall, H. I., Hu, X., Guo, X., & Song, R. (2012). A county-level examination of the relationship between HIV and social determinants of health: 40 states, 2006–2008. The Open AIDS Journal, 6, 1–7. doi: 10.2174/1874613601206010001
  • Gardner, E. M., McLees, M. P., Steiner, J. F., Del Rio, C., & Burman, W. J. (2011). The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clinical Infectious Diseases, 52(6), 793–800. doi: 10.1093/cid/ciq243
  • Gordon, D. (2011). Relative frequency of different below-limit VL ranges over time. S. L. Braunstein.
  • Govindasamy, D., Ford, N., & Kranzer, K. (2012). Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: A systematic review. AIDS (London, England), 26(16), 2059–2067. doi: 10.1097/QAD.0b013e3283578b9b
  • Handford, C., Rackal, J., Tynan, A., Rzeznikiewiz, D., & Glazier, R. (2012). The association of hospital, clinic and provider volume with HIV/AIDS care and mortality: Systematic review and metaanalysis. AIDS Care: Psychological and Socio-Medical Aspects of AIDS/HIV, 24(3), 267–282. doi: 10.1080/09540121.2011.608419
  • The Henry J. Kaiser Family Foundation. (2014). State health facts: HIV/AIDS. Menlo Park, CA: Author.
  • Ickovics, J. R., & Meade, C. S. (2002). Adherence to antiretroviral therapy among patients with HIV: A critical link between behavioral and biomedical sciences. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S98–S102. doi: 10.1097/00126334-200212153-00002
  • Irvine, M. K., Chamberlin, S. A., Robbins, R. S., Myers, J. E., Braunstein, S. L., Mitts, B. J. (2015). Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program. Clinical Infectious Diseases, 60(2), 298–310. doi: 10.1093/cid/ciu783
  • Joy, R., Druyts, E. F., Brandson, E. K., Lima, V. D., Rustad, C. A., Zhang, W., & Hogg, R. S. (2008). Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. Journal of Acquired Immune Deficiency Syndromes, 47(4), 500–505. doi: 10.1097/QAI.0b013e3181648dfd
  • Kaplan, J. E., Hanson, D. L., Jones, J. L., Dworkin, M. S., & Adult and Adolescent Spectrum of HIV Disease Project Investigators. (2001). Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents. AIDS (London, England), 15(14), 1831–1836. doi: 10.1097/00002030-200109280-00012
  • Keller, S. C., Yehia, B. R., Momplaisir, F. O., Eberhart, M. G., Share, A., & Brady, K. A. (2014). Assessing the overall quality of health care in persons living with HIV in an urban environment. AIDS Patient Care and STDs, 28(4), 198–205. doi: 10.1089/apc.2014.0001
  • Kitahata, M. M., Van Rompaey, S. E., & Shields, A. W. (2000). Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 24(2), 106–114. doi: 10.1097/00042560-200006010-00004
  • Lee, E. W., Wei, L. J., & Amato, D. A. (1992). Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In J. P. Klein, & P. K. Goel (Eds.), Survival analysis: State of the art. Dordrecht: Kluwer Academic Publishers.
  • Lin, D. Y., & Wei, L. J. (1989). The robust inference for the Cox proportional hazards model. Journal of the American Statistical Association, 84(408), 1074–1078. doi: 10.1080/01621459.1989.10478874
  • McNaghten, A. D., Valverde, E. E., Blair, J. M., Johnson, C. H., Freedman, M. S., & Sullivan, P. S. (2013). Routine HIV testing among providers of HIV care in the United States, 2009. PloS one, 8(1), e51231. doi: 10.1371/journal.pone.0051231
  • Millett, G. A., Peterson, J. L., Flores, S. A., Hart, T. A., Jeffries, W. L. T., Wilson, P. A., & Remis, R. S. (2012). Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: A meta-analysis. The Lancet, 380(9839), 341–348. doi: 10.1016/S0140-6736(12)60899-X
  • Moore, R. D., & Bartlett, J. G. (2011). Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. Clinical Infectious Diseases, 53(6), 600–604. doi: 10.1093/cid/cir467
  • New York City Department of Health and Mental Hygiene. (2018). Care and clinical status of people newly diagnosed with HIV and people living with HIV/AIDS in New York City, 2017. New York. https://www1.nyc.gov/assets/doh/downloads/pdf/dires/hiv-related-medical-care.pdf
  • Novak, R. M., Hart, R. L., Chmiel, J. S., Brooks, J. T., Buchacz, K., & HIV Outpatient Study (HOPS) Investigators. (2015). Disparities in initiation of combination antiretroviral treatment and in virologic suppression among patients in the HIV outpatient study (HOPS), 2000–2013. Journal of Acquired Immune Deficiency Syndromes, 70(1), 23–32. doi: 10.1097/QAI.0000000000000652
  • O'Connell, D. A., Martin, E. G., Cutler, B., & Birkhead, G. S. (2015). The evolution of HIV testing requirements in New York State, 1989–2013. Journal of Acquired Immune Deficiency Syndromes, 68(Suppl. 1), S5–S9. doi: 10.1097/QAI.0000000000000422
  • O'Neill, M., Karelas, G. D., Feller, D. J., Knudsen-Strong, E., Lajeunesse, D., Tsui, D., & Agins, B. D. (2015). The HIV Workforce in New York State: Does patient volume Correlate with quality? Clinical Infectious Diseases, 61(12), 1871–1877. doi: 10.1093/cid/civ719
  • Panel on Antiretroviral Guidelines for Adults and Adolescents. (2007). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. In: Department of Health and Human Services; December 1.
  • Panel on Antiretroviral Guidelines for Adults and Adolescents. (2009). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. In: Department of Health and Human Services; December 1.
  • Panel on Antiretroviral Guidelines for Adults and Adolescents. (2012). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. In: Department of Health and Human Services; March 27.
  • Panel on Clinical Practices for Treatment of HIV Infection. (2005). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. In: Department of Health and Human Services; April 7.
  • Paredes, R., Mocroft, A., Kirk, O., Lazzarin, A., Barton, S. E., van Lunzen, J., & Clotet, B. (2000). Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: Results from the EuroSIDA study. Archives of Internal Medicine, 160(8), 1123–1132. doi: 10.1001/archinte.160.8.1123
  • Phillips, A. N., Staszewski, S., Weber, R., Kirk, O., Francioli, P., Miller, V., & EuroSIDA Study Group. (2001). HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA, 286(20), 2560–2567. doi: 10.1001/jama.286.20.2560
  • Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., & Gray, R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project study group. New England Journal of Medicine, 342(13), 921–929. doi: 10.1056/NEJM200003303421303
  • Shacham, E., Nurutdinova, D., Onen, N., Stamm, K., & Overton, E. T. (2010). The interplay of sociodemographic factors on virologic suppression among a U.S. Outpatient HIV clinic population. AIDS Patient Care and STDs, 24(4), 229–235. doi: 10.1089/apc.2009.0275
  • Soon, G. G., Min, M., Struble, K. A., Chan-Tack, K. M., Hammerstrom, T., Qi, K., & Birnkrant, D. B. (2012). Meta-Analysis of Gender differences in Efficacy outcomes for HIV-positive Subjects in Randomized Controlled clinical Trials of Antiretroviral therapy (2000–2008). AIDS Patient Care and STDs, 26(8), 444–453. doi: 10.1089/apc.2011.0278
  • Spinks, T., Albright, H. W., Feeley, T. W., Walters, R., Burke, T. W., Aloia, T., & Shine, K. I. (2012). Ensuring quality cancer care: A follow-up review of the Institute of Medicine's ten recommendations for improving the quality of cancer care in America. Cancer, 118(10), 2571–2582. doi: 10.1002/cncr.26536
  • Stadelmann, L., Terzian, A., Irvine, M., Braunstein, S., & Shepard, C. (2013). Changes in HIV viral load suppression among HIV+ New Yorkers, 2006–2007 to 2010–2011. In Conference on Retroviruses and Opportunistic Infections. Atlanta.
  • Stub, D., Smith, K., Bray, J. E., Bernard, S., Duffy, S. J., & Kaye, D. M. (2011). Hospital characteristics are associated with patient outcomes following out-of-hospital cardiac arrest. Heart, 97(18), 1489–1494. doi: 10.1136/hrt.2011.226431
  • Terzian, A. S., Bodach, S. D., Wiewel, E. W., Sepkowitz, K., Bernard, M. A., Braunstein, S. L., & Shepard, C. W. (2012). Novel use of surveillance data to detect HIV-infected persons with sustained high viral load and durable virologic suppression in New York City. PloS one, 7(1), e29679. doi: 10.1371/journal.pone.0029679
  • Terzian, A. S., Irvine, M. K., Hollod, L. M., Lim, S., Rojas, J., & Shepard, C. W. (2015). Effect of HIV housing services on engagement in care and treatment, New York City, 2011. AIDS and Behavior, 19(11), 2087–2096. doi: 10.1007/s10461-015-1003-4
  • Torian, L. V., & Wiewel, E. W. (2011). Continuity of HIV-related medical care, New York City, 2005–2009: Do patients who initiate care stay in care? AIDS Patient Care and STDs, 25(2), 79–88. doi: 10.1089/apc.2010.0151
  • Torian, L. V., Wiewel, E. W., Liu, K. L., Sackoff, J. E., & Frieden, T. R. (2008). Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Archives of Internal Medicine, 168(11), 1181–1187. doi: 10.1001/archinte.168.11.1181
  • Torian, L. V., & Xia, Q. (2013). Achievement and maintenance of viral suppression in persons newly diagnosed with HIV, New York City, 2006–2009: Using population surveillance data to measure the treatment part of “test and treat”. Journal of Acquired Immune Deficiency Syndromes, 63(3), 379–386. doi: 10.1097/QAI.0b013e3182926b02
  • Torian, L. V., Xia, Q., & Wiewel, E. W. (2014). Retention in care and viral suppression among persons living with HIV/AIDS in New York City, 2006–2010. American Journal of Public Health, 104(9), e24–e29. doi: 10.2105/AJPH.2014.302080
  • Valdez, H., Lederman, M., Woolley, I., Walker, C. J., Vernon, L. T., Hise, A., & Gripshover, B. M. (1999). Human immunodeficiency virus 1 protease inhibitors in clinical practice: Predictors of virological outcome. Archives of Internal Medicine, 159(15), 1771–1776. doi: 10.1001/archinte.159.15.1771
  • Weintrob, A. C., Grandits, G. A., Agan, B. K., Ganesan, A., Landrum, M. L., Crum-Cianflone, N. F., & IDCRP HIV Working Group. (2009). Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care. Journal of Acquired Immune Deficiency Syndromes, 52(5), 574–580. doi: 10.1097/QAI.0b013e3181b98537
  • The White House Office of National AIDS Policy. (July 2010). National HIV/AIDS Strategy for the United States. Washington, D.C.
  • Wiewel, E. W., Braunstein, S. L., Xia, Q., Shepard, C. W., & Torian, L. V. (2015). Monitoring outcomes for newly diagnosed and prevalent HIV cases using a care continuum created with New York City surveillance data. Journal of Acquired Immune Deficiency Syndromes, 68(2), 217–226. doi: 10.1097/QAI.0000000000000424
  • Willis, S., Castel, A. D., Ahmed, T., Olejemeh, C., Frison, L., & Kharfen, M. (2013). Linkage, engagement, and viral suppression rates among HIV-infected persons receiving care at medical case management programs in Washington, DC. Journal of Acquired Immune Deficiency Syndromes, 64(Suppl 1), S33–S41. doi: 10.1097/QAI.0b013e3182a99b67
  • Wood, E., Montaner, J. S., Chan, K., Tyndall, M. W., Schechter, M. T., Bangsberg, D., & Hogg, R. S. (2002). Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS (London, England), 16(15), 2065–2072. doi: 10.1097/00002030-200210180-00012
  • Xia, Q., Wiewel, E. W., Braunstein, S. L., Kersanske, L. S., & Torian, L. V. (2015). Comparison of indicators measuring the proportion of human immunodeficiency virus-infected persons with a suppressed viral load. Annals of Epidemiology.
  • Yehia, B. R., Fleishman, J. A., Metlay, J. P., Moore, R. D., & Gebo, K. A. (2012). Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA, 308(4), 339–342. doi: 10.1001/jama.2012.5927

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.